envelop
anim
virus
human
immunodefici
viru
hiv
hepat
b
viru
hepat
c
viru
human
papillomaviru
marburg
influenza
major
public
health
concern
around
world
prohibit
cost
antiretrovir
arv
drug
hivinfect
patient
subsaharan
africa
seriou
side
effect
access
arv
drug
make
compel
case
studi
complementari
altern
therapi
therapi
scientif
prove
antivir
activ
minim
toxic
effect
plant
extract
secometv
anecdot
indic
human
promis
antihiv
treatment
investig
use
previous
describ
attenu
vaccinia
viru
establish
antivir
activ
secometv
chemic
analysi
show
acid
ph
nontox
trace
iron
ppm
almost
undetect
level
arsen
ppm
color
vari
colorless
pale
yellow
dark
brown
activ
agent
heat
stabl
least
steril
temperatur
crude
plant
extract
mixtur
sever
small
molecul
separ
highpressur
liquid
chromatographi
hiv
viral
load
significantli
reduc
sever
month
patient
monitor
treatment
secometv
secometv
also
found
antivir
activ
sar
viru
west
nile
viru
secometv
therefor
annal
new
york
academi
scienc
broadspectrum
antivir
possibl
work
neutral
viral
infect
result
prevent
viral
attach
envelop
virus
human
immunodefici
viru
hiv
hepat
b
viru
influenza
viru
remain
major
threat
human
health
worldwid
infect
billion
peopl
togeth
three
virus
affect
least
million
individu
roughli
south
african
popul
caus
consider
morbid
mortal
hiv
result
million
total
death
worldwid
estim
million
peopl
infect
south
africa
alon
data
provid
unaid
combat
diseas
caus
hiv
envelopedvirus
sustain
multiprong
approach
need
one
describ
previous
one
power
weapon
hiv
lifeprolong
drug
cocktail
aid
treatment
unfortun
avail
drug
cocktail
limit
small
fraction
infect
high
cost
treatment
make
matter
wors
also
sever
side
effect
seen
peopl
take
drug
therefor
urgent
need
continu
search
new
therapi
may
effect
new
antivir
drug
envelop
virus
variola
viru
caus
agent
smallpox
consid
prime
candid
bioweapon
aftermath
terrorist
attack
addit
emerg
monkeypox
diseasecaus
agent
democrat
republ
congo
drc
central
africa
emphas
need
continu
search
antivir
agent
envelop
virus
promis
chemotherapi
poxvirus
summar
fig
complic
vaccin
smallpox
vaccinia
viru
seem
quit
bleak
sever
side
effect
addit
loom
threat
influenza
pandem
lack
reliabl
treatment
leav
world
vulner
upcom
emerg
new
virul
strain
spread
sarscaus
viru
nip
bud
end
mean
complac
readi
dispens
repertoir
antiserum
treatment
antivir
drug
would
best
ammunit
bolster
prepared
agent
centuri
human
look
find
natur
solut
health
problem
recent
plant
focu
sever
investig
around
world
search
antivir
agent
base
interest
anecdot
evid
suggest
properti
protect
viral
infect
potenti
promis
plant
extract
develop
reliabl
scientif
evid
need
indic
extract
truli
worth
consid
potenti
treatment
viral
infect
research
justifi
wellestablish
infrastructur
methodolog
cultiv
titer
virus
accur
evalu
antivir
effect
possibl
show
inde
small
volum
plant
extract
term
secometv
abl
inactiv
approxim
million
viru
particl
attenu
recombin
vaccinia
viru
minut
consist
reproduc
recombin
attenu
viru
chosen
grow
well
wildtyp
western
reserv
strain
vaccinia
viru
cell
cultur
use
highli
attenu
strain
also
rel
safe
lack
neurovirul
factor
attribut
inabl
replic
brain
caus
complic
anecdot
evid
human
indic
plant
extract
benefici
effect
common
cold
influenza
viru
hiv
secometv
regist
herbal
medicin
provid
secomet
compani
patient
access
antiretrovir
arv
drug
care
certifi
physician
viral
load
patient
decreas
significantli
nearli
minim
level
among
compliant
patient
indic
extract
inde
posit
effect
viremia
level
decreas
rapidli
arv
therapi
highli
activ
antiretrovir
therapi
haart
howev
signific
side
effect
secometv
diseas
symptom
reduc
consider
soon
treatment
clear
amount
activ
ingredi
plant
extract
need
identifi
increas
besid
increas
efficaci
activ
ingredi
identifi
purifi
character
hope
reduc
compon
may
caus
toxic
becom
evid
chang
process
plant
extract
avoid
addit
charcoal
well
use
ultrafiltr
cutoff
filter
greatli
reduc
longterm
shortterm
toxic
secometv
broadspectrum
agent
potenti
safe
highli
efficaci
antivir
therapi
identifi
activ
ingredi
would
character
extract
fullest
extent
possibl
major
impact
develop
new
synthet
antivir
origin
natur
sourc
anoth
advantag
identifi
bioactiv
gredient
would
understand
mechan
action
secometv
current
evid
indic
mechan
action
render
viru
noninfecti
subsequ
block
viral
attach
attenu
recombin
vaccinia
viru
produc
cell
chicken
egg
requir
quantiti
titer
presenc
absenc
plant
extract
fraction
highpressur
liquid
chromatographi
hplc
column
describ
earlier
essenti
approxim
million
viru
particl
mix
secometv
two
differ
cell
line
ccrf
cem
cem
use
infect
subtyp
b
hiv
viru
plant
extract
dilut
phosphatebuff
salin
experi
plate
use
plate
follow
ad
ml
medium
pen
strep
infect
ccrf
cem
pgml
infect
cem
pgml
vari
amount
plant
extract
neg
control
uninfect
cell
line
set
parallel
infect
cell
line
posit
control
infect
cell
line
day
supernat
collect
look
direct
effect
bioactiv
molecul
hiv
infect
pure
viru
stock
million
viru
particl
vari
amount
purifi
bioactiv
molecul
treat
compar
untreat
sampl
assay
surviv
viru
without
treatment
also
compar
addit
antihiv
assay
perform
directli
secometv
direct
contact
hiv
virolog
inc
south
san
francisco
ca
vari
amount
african
green
monkey
kidney
cell
line
cell
monolay
confluent
plate
treat
vari
amount
purifi
fraction
stain
crystal
violet
determin
cell
cytox
judg
integr
monolay
secometv
vari
color
almost
colorless
filter
cutoff
filter
dark
brown
unfilt
bioactiv
agent
therefor
smaller
close
da
size
autoclav
elimin
activ
suggest
bioactiv
agent
heat
stabl
least
ph
undilut
extract
approxim
viru
come
contact
extract
buffer
ph
medium
approxim
dri
weight
vari
approxim
mgml
mgml
base
ultrafiltr
cutoff
arsen
undetect
iron
ppm
content
found
well
toxic
level
within
limit
prescrib
nation
formulari
usa
analyz
use
perkinelm
atom
absorpt
spectrophotomet
forens
chemistri
lab
western
cape
polic
depart
cape
town
south
africa
subject
complain
tast
suggest
least
toler
tast
secometv
extract
african
plant
also
found
elsewher
asia
found
potent
antivir
activ
poxviru
vaccinia
viru
render
million
particl
noninfecti
min
millilit
vitro
assay
fig
independ
report
antihiv
test
done
virolog
inc
mix
viru
extract
shown
hiv
particl
neutral
secometv
extract
fail
caus
reduct
viru
titer
cell
first
infect
directli
follow
addit
plant
extract
indic
secometv
neutral
viral
infect
inhibit
postentri
step
life
cycl
viru
hivinfect
cell
treat
plant
extract
show
signific
effect
viral
level
tabl
therefor
appar
effect
life
cycl
hiv
enter
cell
also
observ
infect
secometv
ad
viru
allow
attach
intern
h
signific
effect
viru
replic
plaqu
format
confirm
hypothesi
one
small
molecul
plant
extract
yet
unknown
mechan
render
viru
noninfecti
suggest
viru
enter
cell
extract
longer
effect
key
find
indic
like
secometv
act
broadspectrum
inhibitor
viral
entri
novel
mechan
inhibit
would
problem
resist
common
arv
well
problem
viral
evas
due
chang
surfac
glycoprotein
amino
acid
sequenc
determin
whether
secometv
abl
reduc
viremia
four
hiv
patient
infect
subtyp
c
fullblown
aid
given
plant
extract
patient
access
arv
count
decreas
quit
significantli
prior
treatment
secometv
viral
load
found
significantli
reduc
within
month
observ
fig
b
sar
corona
viru
also
found
render
inact
secometv
data
shown
test
along
agent
code
panel
west
nile
viru
similarli
test
secometv
effect
west
nile
viru
concentr
virus
inactiv
dri
weight
ml
crude
plant
extract
approxim
mg
ultrafilt
cutoff
plant
extract
mg
differ
effect
plant
extract
render
vaccinia
viru
noninfecti
whether
autoclav
suggest
bioactiv
agent
like
necessarili
heatstabl
compound
small
peptid
preliminari
hplc
separ
ultrafilt
plant
extract
column
show
major
peak
minor
peak
approxim
quit
tini
peak
previous
shown
trifollium
speci
flavanoid
salicyl
acid
besid
test
efficaci
preliminari
studi
complet
determin
shortterm
longterm
toxic
extract
simpl
assay
vari
amount
extract
ad
million
african
green
monkey
kidney
cell
cell
found
extract
render
half
million
viru
particl
inact
plant
extract
ad
monolay
becam
detach
extract
toler
cytotox
present
therefor
concentr
toxic
dose
viru
render
inact
extract
filter
filter
toxic
diminish
antivir
activ
remain
intact
similar
studi
conduct
potenti
longterm
effect
crude
extract
ballardin
et
al
volum
could
carcinogen
secometv
test
mutagen
use
ame
gene
mutat
test
salmonella
chromosom
damag
clastogen
micronucleu
test
human
lymphocyt
crude
extract
present
weak
clastogen
activ
power
mutagen
activ
ame
test
addit
exogen
metabol
activ
purif
extract
without
addit
charcoal
result
drastic
reduct
extract
mutagen
virtual
reduc
mean
ultrafiltr
cutoff
da
ultrafiltr
almost
elimin
shortterm
longterm
toxic
molecul
pure
bioactiv
molecul
like
free
toxic
associ
crude
extract
find
open
new
possibl
hiv
therapi
secometv
devoid
mutagen
activ
reduc
possibl
induct
resist
viral
strain
previou
arv
drug
